While cases of neurodegenerative diseases are on the rise, scientists have examined the role of environmental factors. Recent ...

Protein aggregates, damaged organelles, and invading bacteria are identified and removed in healthy cells. An international ...

When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, ...

Prefoldin 5 stabilises neuronal microtubules and suppresses Tau-mediated neurotoxicity, offering a potential therapeutic target for tauopathies.

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and ...

Share on PinterestA new drug shows promise by reversing mental decline in mouse models of advanced Alzheimer’s disease. Image credit: VICTOR TORRES/Stocksy For many years, scientists have considered ...

Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...